Lanlan Yu
Impact in
- Immunology top 2%
- Immune cells in cancer
- Oncology top 2%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Angiogenesis and VEGF in Cancer 7
- Genomics and Chromatin Dynamics 3
- RNA Research and Splicing 2
-
- Protease and Inhibitor Mechanisms 3
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Napoleone Ferrara (12 shared papers)Martin A. Gorovsky (4 shared papers)Xiumin Wu (6 shared papers)Cuiling Zhong (3 shared papers)C. David Allis (1 shared paper)Wei Yi (1 shared paper)Josephine Bowen (1 shared paper)Y. Gloria Meng (4 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Cell (2 papers)The EMBO Journal (2 papers)Biochemical and Biophysical Research Communications (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesChinaSingapore
In The Last Decade
Lanlan Yu
20 papers receiving 3.7k citations
Lanlan Yu's Hit Papers
Peers
Comparison fields: 5 of 96
- Immunology 1.1k
- Oncology 1.3k
- Cancer Research 686
- Molecular Biology 2.1k
- Ophthalmology 165
Countries citing papers authored by Lanlan Yu
This map shows the geographic impact of Lanlan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Yu more than expected).
Fields of papers citing papers by Lanlan Yu
This network shows the impact of papers produced by Lanlan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Yu. The network helps show where Lanlan Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lanlan Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phosphorylation of Histone H3 Is Required for Proper Chromosome Condensation and Segregation Hit paper breakdown → | 1999 | 585 |
| 2 | Bv8 regulates myeloid-cell-dependent tumour angiogenesis Hit paper breakdown → | 2007 | 530 |
| 3 | Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes Hit paper breakdown → | 2010 | 512 |
| 4 | 2009 | 485 | |
| 5 | 2009 | 394 | |
| 6 | 1995 | 249 | |
| 7 | 2004 | 228 | |
| 8 | 2000 | 145 | |
| 9 | 2008 | 139 | |
| 10 | 2008 | 128 | |
| 11 | 2006 | 95 | |
| 12 | 2012 | 78 | |
| 13 | 2007 | 77 | |
| 14 | 2011 | 72 | |
| 15 | 2014 | 71 | |
| 16 | 1997 | 40 | |
| 17 | 1978 | 22 | |
| 18 | 2018 | 11 | |
| 19 | 1999 | 4 | |
| 20 | 2023 | 1 |
About Lanlan Yu
Lanlan Yu is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Cell Biology, having authored 20 papers that have together received 3.9k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (7 papers), Protease and Inhibitor Mechanisms (3 papers), Cancer Cells and Metastasis (3 papers), Immune cells in cancer (3 papers), Genomics and Chromatin Dynamics (3 papers), Proteoglycans and glycosaminoglycans research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (1.3k citations), Cancer Research (686 citations), Molecular Biology (2.1k citations) and Ophthalmology (165 citations). Lanlan Yu has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Napoleone Ferrara, Martin A. Gorovsky, Xiumin Wu, Cuiling Zhong, C. David Allis, Wei Yi, Josephine Bowen, Y. Gloria Meng, Farbod Shojaei and Xueping Qu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cell, The EMBO Journal, Biochemical and Biophysical Research Communications and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.